Endemic Burkitt's lymphoma as a polymicrobial disease. New insights on the interaction between Plasmodium falciparum and Epstein-Barr virus

Seminars in Cancer Biology

Volumn 19, Issue 6, 2009, Pages 411-420

  Chene, Arnaud ^a,b   Donati, Daria ^b   Orem, Jackson ^c   Mbidde, E R ^d   Kironde, Fred ^c   Wahlgren, Mats ^a   Bejarano, Maria Teresa ^b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c MAKERERE UNIVERSITY   (Uganda)

^d UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

Author keywords

PfEMP1; Plasmodium falciparum

Indexed keywords

ANTIMALARIAL AGENT; ERYTHROCYTE MEMBRANE PROTEIN 1; IMMUNOGLOBULIN; MYC PROTEIN; VIRUS DNA;

B LYMPHOCYTE ACTIVATION; BURKITT LYMPHOMA; CANCER RISK; CELL SURVIVAL; CHROMOSOME TRANSLOCATION; ENDEMIC DISEASE; EPSTEIN BARR VIRUS; ERYTHROCYTE ADHESIVENESS; HUMAN; LATENT VIRUS INFECTION; MALARIA; MEMORY CELL; NONHUMAN; PLASMODIUM FALCIPARUM; REVIEW; VIRUS CARCINOGENESIS; VIRUS LOAD; VIRUS REACTIVATION;

ANIMALS; BURKITT LYMPHOMA; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; VIRUS ACTIVATION;

EID: 70949092034     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2009.10.002     Document Type: Review

References (99)

1. Abele D.C., Tobie J.E., Hill G.J., Contacos P.G., and Evans C.B. Alterations in serum proteins and 19s antibody production during the course of induced malarial infections in man. Am J Trop Med Hyg 14 (1965) 191-197
2. Adu D., Williams D.G., Quakyi I.A., Voller A., Anim-Addo Y., Bruce-Tagoe A.A., et al. Anti-ssDNA and antinuclear antibodies in human malaria. Clin Exp Immunol 49 (1982) 310-316
3. Anderton E., Yee J., Smith P., Crook T., White R.E., and Allday M.J. Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene 27 (2008) 421-433
4. Araujo I., Foss H.D., Hummel M., Anagnostopoulos I., Barbosa H.S., Bittencourt A., et al. Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma. J Pathol 187 (1999) 326-333
5. Asito A.S., Moormann A.M., Kiprotich C., Ng'ang'a Z.W., Ploutz-Snyder R., and Rochford R. Alterations on peripheral B cell subsets following an acute uncomplicated clinical malaria infection in children. Malar J 7 (2008) 238
6. Babcock G.J., Decker L.L., Volk M., and Thorley-Lawson D.A. EBV persistence in memory B cells in vivo. Immunity 9 (1998) 395-404
7. Baldanti F., Grossi P., Furione M., Simoncini L., Sarasini A., Comoli P., et al. High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J Clin Microbiol 38 (2000) 613-619
8. Barragan A., Fernandez V., Chen Q., von Euler A., Wahlgren M., and Spillmann D. The Duffy-binding-like domain 1 of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a heparan sulfate ligand that requires 12 mers for binding. Blood 95 (2000) 3594-3599
9. Baruch D.I., Pasloske B.L., Singh H.B., Bi X., Ma X.C., Feldman M., et al. Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 82 (1995) 77-87
10. Bende R.J., van Maldegem F., Triesscheijn M., Wormhoudt T.A., Guijt R., and van Noesel C.J. Germinal centers in human lymph nodes contain reactivated memory B cells. J Exp Med 204 (2007) 2655-2665
11. Berger C., Day P., Meier G., Zingg W., Bossart W., and Nadal D. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease. J Med Virol 64 (2001) 505-512
12. Biggar R.J., Henle G., Böcker J., Lennette E.T., Fleisher G., and Henle W. Primary Epstein-Barr virus infections in African infants. II. Clinical and serological observations during seroconversion. Int J Cancer 22 (1978) 244-250
13. Biggar R.J., Henle W., Fleisher G., Böcker J., Lennette E.T., and Henle G. Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer 22 (1978) 239-243
14. Björkman A. Malaria epidemiology, drug protection and drug susceptibility in a holoendemic area of Liberia. Karolinska Institutet, PhD Thesis; 1985.
15. Blake N., Lee S., Redchenko I., Thomas W., Steven N., Leese A., et al. Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity 7 (1997) 791-802
16. Bossolasco S., Cinque P., Ponzoni M., Vigano M.G., Lazzarin A., Linde A., et al. Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma. J Neurovirol 8 (2002) 432-438
17. Boxer L.M., and Dang C.V. Translocations involving c-myc and c-myc function. Oncogene 20 (2001) 5595-5610
18. Broccolo F., Bossolasco S., Careddu A.M., Tambussi G., Lazzarin A., and Cinque P. Detection of DNA of lymphotropic herpesviruses in plasma of human immunodeficiency virus-infected patients: frequency and clinical significance. Clin Diagn Lab Immunol 9 (2002) 1222-1228
19. Burkitt D. A sarcoma involving the jaws in African children. Br J Surg 46 (1958) 218-223
20. Burkitt D. Determining the climatic limitations of a children's cancer common in Africa. Br Med J 2 (1962) 1019-1023
21. Chen Q., Fernandez V., Sundström A., Schlichtherle M., Datta S., Hagblom P., et al. Developmental selection of var gene expression in Plasmodium falciparum. Nature 394 (1998) 392-395 [Comments see: Nature doi:10.1038/news980730-2]
22. Chen Q., Heddini A., Barragan A., Fernandez V., Pearce S.F., and Wahlgren M. The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors. J Exp Med 192 (2000) 1-10
23. Chene A, Bejarano MT, Wahlgren M, Falk K. Herpes viruses activated during malaria-infections present in saliva and blood, submitted for publication.
24. Chene A., Donati D., Guerreiro-Cacais A.O., Levitsky V., Chen Q., Falk K.I., et al. A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathog 3 June (6) (2007) e80
25. Crabb B.S., Cooke B.M., Reeder J.C., Waller R.F., Caruana S.R., Davern K.M., et al. Targeted gene disruption shows that knobs enable malaria-infected red cells to cytoadhere under physiological shear stress. Cell 89 (1997) 287-296
26. Daniel-Ribeiro C., de Oliveira-Ferreira J., Banic D.M., and Galvao-Castro B. Can malaria-associated polyclonal B-lymphocyte activation interfere with the development of anti-sporozoite specific immunity?. Trans R Soc Trop Med Hyg 83 (1989) 289-292
27. Dardari R., Khyatti M., Benider A., Jouhadi H., Kahlain A., Cochet C., et al. Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma. Int J Cancer 86 (2000) 71-75
28. de-The G., Geser A., Day N.E., Tukei P.M., Williams E.H., Beri D.P., et al. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 274 (1978) 756-761
29. Depoil D., Fleire S., Treanor B.L., Weber M., Harwood N.E., Marchbank K.L., et al. CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand. Nat Immunol 9 (2008) 63-72
30. Donati D., Zhang L.P., Chen Q., Chene A., Flick K., Wahlgren M., et al. Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect Immun 72 (2004) 5412-5418
31. Donati D., Espmark E., Kironde F., Mbidde E.K., Kamya M., Lundkvist A., et al. Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment. J Infect Dis 193 (2006) 971-977
32. Donati D. Malaria, B lymphocytes and Epstein-Barr virus. PhD Thesis, Karolinska Institutet; 2005, ISBN 91-7140-403-1.
33. Donati D., Mok B., Chene A., Xu H., Thangarajh M., Glas R., et al. Increased B cell survival and preferential activation of the memory compartment by a malaria polyclonal B cell activator. J Immunol 177 (2006) 303i-344i
34. Epstein M.A., Achong B.G., and Barr Y.M. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1 (1964) 702-703
35. Epstein M.A., Henle G., Achong B.G., and Barr Y.M. Morphological and biological studies on a virus in cultured lymphoblasts from Burkitt's lymphoma. J Exp Med 121 (1965) 761-770
36. Fernandez V., Hommel M., Chen Q., and Wahlgren M. Small, clonally-variant antigens expressed at the surface of P. falciparum infected erythrocytes are encoded by the rif-gene-family and are the target of human immune responses. J Exp Med 190 (1999) 1393-1403
37. Fleire S.J., Goldman J.P., Carrasco Y.R., Weber M., Bray D., and Batista F.D. B cell ligand discrimination through a spreading and contraction response. Science 312 (2006) 738-741
38. Flick K., Scholander C., Chen Q., Fernandez V., Bruno Puvelle, Jurg Gysin, et al. Role of non-immune IgG bound to PfEMP1 in the sequestration of Plasmodium falciparum infected erythrocytres in the human placenta. Science 293 (2001) 2098-2100 [Comments: Science p. 2009-10]
39. Graille M., Stura E.A., Corper A.L., Sutton B.J., Taussig M.J., Charbonnier J.B., et al. Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. Proc Natl Acad Sci U S A 97 (2000) 5399-5404
40. Greenwood B.M., and Vick R.M. Evidence for a malaria mitogen in human malaria. Nature 257 (1975) 592-594
41. He B., Raab-Traub N., Casali P., and Cerutti A. EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching. J Immunol 171 (2003) 5215-5224
42. Heddini A., Treutiger C.J., and Wahlgren M. Enrichment of Plasmodium falciparum-infected erythrocytes in a single step on immunoglobulin-coated magnetic beads. Am J Trop Med Hyg 59 5 (1998) 663-666
43. Heddini A., Pettersson F., Kai O., Shafi J., Obiero J., Chen Q.J., et al. Fresh isolates from children with severe Plasmodium falciparum malaria bind to multiple receptors. Infect Immun 69 (2001) 5849-5856
44. Helmby H., Cavelier L., Pettersson U., and Wahlgren M. Plasmodium falciparum infected erythrocytes express unique strain specific antigens on their surface. Infect Immun 61 (1993) 2884-2888
45. Henle G., Henle W., Clifford P., Diehl V., Kafuko G.W., Kirya B.G., et al. Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst 43 (1969) 1147-1157
46. Henshall T.L., Jones K.L., Wilkinson R., and Jackson D.E. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling. J Immunol 166 (2001) 3098-3106
47. Hopwood P., and Crawford D.H. The role of EBV in post-transplant malignancies: a review. J Clin Pathol 53 (2000) 248-254
48. Jackson D.E., Gully L.M., Henshall T.L., Mardell C.E., and Macardle P.J. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) is associated with a naive B-cell phenotype in human tonsils. Tissue Antigens 56 (2000) 105-116
49. Kataaha P.K., Facer C.A., Mortazavi-Milani S.M., Stierle H., and Holborow E.J. Stimulation of autoantibody production in normal blood lymphocytes by malaria culture supernatants. Parasite Immunol 6 (1984) 481-492
50. Kyes S.A., Rowe J.A., Kriek N., and Newbold C.I. Rifins: a second family of clonally variant proteins expressed on the surface of red cells infected with Plasmodium falciparum. Proc Natl Acad Sci U S A 96 (1999) 9333-9338
51. Kennedy G., Komano J., and Sugden B. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Proc Natl Acad Sci U S A 100 (2003) 14269-14274
52. Kimura H., Nishikawa K., Hoshino Y., Sofue A., Nishiyama Y., and Morishima T. Monitoring of cell-free viral DNA in primary Epstein-Barr virus infection. Med Microbiol Immunol 188 (2000) 197-202
53. Klein M.M., Gittis A.G., Su H.P., Makobongo M.O., Moore J.M., Singh S., et al. The cysteine-rich interdomain region from the highly variable Plasmodium falciparum erythrocyte membrane protein-1 exhibits a conserved structure. PLoS Pathog 4 (2008) e1000147
54. Kraemer S.M., and Smith J.D. A family affair: var genes, PfEMP1 binding, and malaria disease. Curr Opin Microbiol 9 (2006) 374-380
55. Laichalk L.L., and Thorley-Lawson D.A. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol 79 (2005) 1296-1307
56. Lam K.M., Syed N., Whittle H., and Crawford D.H. Circulating Epstein-Barr virus-carrying B cells in acute malaria. Lancet 337 (1991) 876-878
57. Leonetti M., Galon J., Thai R., Sautes-Fridman C., Moine G., and Menez A. Presentation of antigen in immune complexes is boosted by soluble bacterial immunoglobulin binding proteins. J Exp Med 189 (1999) 1217-1228
58. Moormann A.M., Chelimo K., Sumba O.P., Lutzke M.L., Ploutz-Snyder R., Newton D., et al. Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis 191 (2005) 1233-1238
59. Moormann A.M., Chelimo K., Sumba P.O., Tisch D.J., Rochford R., and Kazura J.W. Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children. J Infect Dis 195 (2007) 799-808
60. Moss D.J., Burrows S.R., Castelino D.J., Kane R.G., Pope J.H., Rickinson A.B., et al. A comparison of Epstein-Barr virus-specific T-cell immunity in malaria-endemic and -nonendemic regions of Papua New Guinea. Int J Cancer 31 (1983) 727-732
61. Muller J.R., Janz S., Goedert J.J., Potter M., and Rabkin C.S. Persistence of immunoglobulin heavy chain/c-myc recombination-positive lymphocyte clones in the blood of human immunodeficiency virus-infected homosexual men. Proc Natl Acad Sci U S A 92 (1995) 6577-6581
62. Nanbo A., Inoue K., Adachi-Takasawa K., and Takada K. Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. EMBO J 21 (2002) 954-965
63. Njie R., Bell A.I., Jia H., Croom-Carter D., Chaganti S., Hislop A.D., et al. The effects of acute malaria on Epstein-Barr virus (EBV) load and EBV-specific T cell immunity in Gambian children. J Infect Dis 199 (2009) 31-38
64. Orem J., Maganda A., Mbidde E.K., and Weiderpass E. Clinical characteristics and outcome of children with Burkitt lymphoma in Uganda according to HIV infection. Pediatr Blood Cancer 52 (2009) 455-458
65. Pegtel D.M., Middeldorp J., and Thorley-Lawson D.A. Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers. J Virol 78 (2004) 12613-12624
66. Perlmann P., and Troye-Blomberg M. Malaria and the immune system in humans. Chem Immunol 80 (2002) 229-242
67. Pettersson F. Sequestration, virulence and future interventions in Plasmodium falciparum malaria. PhD thesis, Karolinska Institutet; 2005, ISBN 91-7140-568-2.
68. Precopio M.L., Sullivan J.L., Willard C., Somasundaran M., and Luzuriaga K. Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection. J Immunol 170 (2003) 2590-2598
69. Rasti N., Wahlgren M., and Chen Q. MiniReview. Molecular aspects of malaria pathogenesis. FEMS Immunol Med Microbiol 41 (2004) 9-26
70. Rasti N., Falk K.I., Donati D., Gyan B.A., Goka B.Q., Troye-Blomberg M., et al. Circulating Epstein-Barr virus in children living in malaria-endemic areas. Scand J Immunol 61 (2005) 461-465
71. Rasti N., Namusoke F., Chene A., Chen Q., Staalsoe T., Klinkert M.Q., et al. Nonimmune immunoglobulin binding and multiple adhesion characterize Plasmodium falciparum-infected erythrocytes of placental origin. Proc Natl Acad Sci U S A 103 (2006) 13795-13800
72. Reth M. Antigen receptor tail clue. Nature 338 (1989) 383-384
73. Ribacke U., Mok B.W., Wirta V., Normark J., Lundeberg J., Kironde F., et al. Genome wide gene amplifications and deletions in Plasmodium falciparum. Mol Biochem Parasitol 155 (2007) 33-44
74. Rickinson A.B., and Moss D.J. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 15 (1997) 405-431
75. Rickinson A.B., and Kieff E. Epstein-Barr virus. Fields Vriology (2001), Lippincott-Raven, Philadelphia p. 2572-627
76. Rochford R., Cannon M.J., and Moormann A.M. Endemic Burkitt's lymphoma: a polymicrobial disease?. Nat Rev Microbiol 3 (2005) 182-187
77. Ruangjirachuporn W., Afzelius B., Helmby H., Hill A.V.S., Greenwood, Carlson J., et al. Ultrastructural analysis of Plasmodium falciparum infected erythrocytes and their cytoadherence to human leukocytes. Am J Trop Med Hyg 64 (1992) 511-519
78. Sixbey J.W., Nedrud J.G., Raab-Traub N., Hanes R.A., and Pagano J.S. Epstein-Barr virus replication in oropharnygeal epithelial cells. N Eng J Med 310 (1984) 1225-1230
79. Scholander C., Treutiger C.J., Hultenby K., and Wahlgren M. Novel fibrillar structure confers adhesive property to malaria-infected erythrocytes. Nat Med 2 (1996) 204-208
80. Scholander C., Carlson J., Kremsner P.G., and Wahlgren M. Extensive immunoglobulin binding of Plasmodium falciparum-infected erythrocytes in a group of children with moderate anemia. Infect Immun 66 (1998) 361-363
81. Scherf A., Hernandez-Rivas R., Buffet P., Bottius E., Benatar C., Pouvelle B., et al. Antigenic variation in malaria: in situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparum. EMBO J 17 (1998) 5418-5426
82. Shih T.A., Roederer M., and Nussenzweig M.C. Role of antigen receptor affinity in T cell-independent antibody responses in vivo. Nat Immunol 3 (2002) 399-406
83. Singh K., Gittis A.G., Nguyen P., Gowda D.C., Miller L.H., and Garboczi D.N. Structure of the DBL3x domain of pregnancy-associated malaria protein VAR2CSA complexed with chondroitin sulfate A. Nat Struct Mol Biol 15 (2008) 932-938
84. Singh S.K., Hora R., Belrhali H., Chitnis C.E., and Sharma A. Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. Nature 439 (2006) 741-744
85. Takada K. Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int J Cancer 33 (1984) 27-32
86. Thorley-Lawson D.A., and Duca K.A. Pathogens cooperate in lymphomagenesis. Nat Med 13 (2007) 906-907
87. Treutiger C.J., Heddini A., Scholander C., Muller W.E., and Wahlgren M. PECAM-1/CD31 an endothelial receptor for binding of Plasmodium falciparum-infected erythrocytes. Nature Med 3 (1997) 1405-1408 [Comments: Nat Med, p. 1315-16]
88. Treutiger C.J., Scholander C., Carlson J., Falksveden L., and Wahlgren M. Roleaux-forming serum proteins are involved in the rosetting of Plasmodium falciparum-infected erythrocytes. Exp Parasitol 93 (1999) 215-224
89. Troye-Blomberg M., Berzins K., and Perlmann P. T-cell control of immunity to the asexual blood stages of the malaria parasite. Crit Rev Immunol 14 (1994) 131-155
90. Tugizov S.M., Berline J.W., and Palefsky J.M. Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med 9 (2003) 307-314
91. Urban B.C., and Roberts D.J. Inhibition of T cell function during malaria: implications for immunology and vaccinology. J Exp Med 197 (2003) 137-141
92. Vogt A.M., Barragan A., Chen Q., Kironde F., Spillmann D., and Wahlgren M. Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1alpha domain of PfEMP1. Blood 101 (2003) 2405-2411
93. Wahlgren M., Berzins K., Perlmann P., and Persson M. Characterisation of the humoral immuneresponse in Plasmodium falciparum malaria. I. Estimation of antibodies to P. falciparum or human erythrocytes by means of microELISA. Clin Exp Immunol 53 (1983) 127-134
94. Wahlgren M. Antigens and antibodies involved in humoral immunity to Plasmodium falciparum. PhD Thesis, Karolinska Institutet; 1986, ISBN 91-7900-026-6.
95. Wahlgren M., Abrahms J., Fernandez V., Azuma M., Torii M., Aikawa M., et al. Adhesion of Plasmoidum falcipartum-infected erythrocytes to human cells and secretion of cytokines (IL1-b, IL-1RA, IL-6, IL-8, IL-10, TGFb, TNFa, G-CSF, GM-CSF). Scand J Immunol 42 (1995) 626-636
96. Wahlgren M., Fernandez F., Chen Q., Svärd S., and Hagblom P. Waves of malarial variations. Cell 96 (1999) 603-606
97. Whittle H.C., Brown J., Marsh K., Greenwood B.M., Seidelin P., Tighe H., et al. T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria. Nature 312 (1984) 449-450
98. Won W.J., Bachmann M.F., and Kearney J.F. CD36 is differentially expressed on B cell subsets during development and in responses to antigen. J Immunol 180 (2008) 230-237
99. Yamauchi Y., Tachiband Y., Maeda A., Wakiguchi H., Usui M., Kurata T., et al. Evaluation of antibodies to the Epstein-Barr virus immediate early gene product ZEBRA by a new enzyme-linked immunosorbent assay. Intervirology 41 (1998) 278-284